![]() |
인쇄하기
취소
|
It is shown that pharmaceutical companies with the high number of sales of other companies’ products are more likely to be stingy about investing money on research and development (R&D).
According to the Yakupdotcom(www.yakup.com)’s analysis of quarterly reports of the top 20 listed pharmaceutical companies in sales, 62% of their revenues were revenues of goods and 31% were from revenues of pr...